Anisatin
Names | |
---|---|
Preferred IUPAC name
(1R,4S,5R,6S,6aR,7R,9R,9aS)-1,5,6a,7-Tetrahydroxy-5,9-dimethylhexahydrospiro[[4,9a]methanocyclopenta[d]oxocine-6,3′-oxetane]-2,2′(1H)-dione | |
Identifiers | |
3D model (
JSmol ) |
|
3DMet | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.208.646 |
KEGG | |
MeSH | Anisatin |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C15H20O8 | |
Molar mass | 328.317 g·mol−1 |
log P | -1.894 |
Acidity (pKa) | 12.005 |
Basicity (pKb) | 1.992 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Anisatin is an extremely
Role in the GABA system
The
GABA system is an important site of action by a variety of chemicals, including alcohols, heavy metals, and insecticides.[5][6] A study conducted on frog spinal cords and rat brains indicated that anisatin was a strong non-competitive GABA antagonist.[5] Anisatin was shown to suppress GABA-induced signals, but when anisatin was added without GABA, there was no change in the signal.[5] Anisatin was also found to share the same binding site as picrotoxinin, and did not cause additional suppression of GABA-induced signals in the presence of high concentrations of picrotoxinin.[5]
Anisatin poisoning has been shown to cause epilepsy, hallucinations, nausea, and convulsions.[7][8] Diazepam has been studied as an anti-convulsive on the GABA system, and has been shown to be an effective treatment for anisatin-induced convulsions.[8]
Synthesis
A total synthesis of (-)-anisatin was reported in 1990.[9]
References
- ^ "Anisatin". PubChem, National Library of Medicine, US National Institutes of Health. 11 May 2019. Retrieved 17 May 2019.
- .
- .
- ^ "Naoru.com:シキミ(Japanese)". Archived from the original on 2018-09-09. Retrieved 2009-03-11.
- ^ PMID 10455311.
- PMID 28606041.
- PMID 26361344.
- ^ PMID 22484123.
- ISSN 0002-7863.
External links
- Media related to Anisatin at Wikimedia Commons